FDA approves the first “artificial pancreas”this week

Medtronics has finally got FDA approval for its first “artificial pancreas” this week.The device consists of a closed loop system that continuously measures a diabetic’s glucose levels and delivers the appropriate dose of basal insulin.It is indicated for people aged 14 or older with Type 1 diabetes and is intended to regulate insulin levels with “little to no input” from the patient.The system comprises an insulin pump that is strapped to the patient body, an infusion patch that delivers insulin via catheter from the pump and a sensor that measures glucose levels under the skin and can be worn for 7 days at a time. While the device regulates basal, or background, insulin, users must still manually request bolus insulin at mealtimes.

The system will hit the market in spring next year.



For more details, refer to the original research article on the following link:



Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s